Magellan Health (MGLN) Misses Q2 EPS by 57c, Beats on Revenues; Offers FY17 Revenue Guidance Above Consensus

Magellan Health (NASDAQ: MGLN) reported Q2 EPS of $0.59, $0.57 worse than the analyst estimate of $1.16. Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.39 billion.

GUIDANCE:

Magellan Health sees FY2017 EPS of $5.08-$5.99, versus the consensus of $5.44. Magellan Health sees FY2017 revenue of $5.795-6.095 billion, versus the consensus of $5.78 billion.

For earnings history and earnings-related data on Magellan Health (MGLN) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
• DA Davidson Reiterates Buy Rating on Boost Run (BRUN)